Citation Impact 2023
Journal Impact Factor: 4.4
5-year Journal Impact Factor: 4.9
Source Normalized Impact per Paper (SNIP): 1.294
SCImago Journal Rank (SJR): 1.518
Speed 2024
Submission to first editorial decision (median days): 11
Submission to acceptance (median days): 118
Usage 2024
Downloads: 3,978,337
Altmetric mentions: 1,452
Supplements
-
Volume 16
Back to top-
At the interface between immunology and endocrinology in rheumatic diseases
Volume 16 Supplement 2
-
Lupus 2014: New Targets, New Approaches
Volume 16 Supplement 1
-
-
Volume 15
Back to top-
Gastroprotective NSAIDS
Volume 15 Supplement 3
-
Treatment of SLE: bridging the gap from clinical trials to the clinic
Volume 15 Supplement 2
-
B cells in autoimmune diseases: Part 2
Volume 15 Supplement 1
-
-
Volume 14
Back to top-
B cells in autoimmune diseases: Part 1
Volume 14 Supplement 5
-
New therapeutic targets in systemic lupus
Volume 14 Supplement 4
-
Lupus 2012: New targets, new approaches
Volume 14 Supplement 3
-
-
Volume 13
Back to top-
Kitasato Symposium 2011: Translational prospects for cytokines in 2011
Volume 13 Supplement 2
-
The evolution of anti-TNF therapy in rheumatic disease: experience, insights and advances
Volume 13 Supplement 1
-
-
Volume 12
Back to top-
The role of IFN alpha in autoimmune disease
Volume 12 Supplement 1
-
-
Volume 11
Back to top -
Volume 10
Back to top-
New insights in the role of nitric oxide in the management of osteoarthritis
Volume 10 Supplement 2
-
Co-stimulation blockade: from bench to bedside
Volume 10 Supplement 1
-
-
Volume 9
Back to top-
6th Global Arthritis Research Network (GARN) Meeting
Volume 9 Supplement 3
-
Advances in systemic sclerosis and related fibrotic and vascular conditions
Volume 9 Supplement 2
-
Basic science, rationale, background and future of denosumab: a RANK ligand inhibitor
Volume 9 Supplement 1
-
-
Volume 8
Back to top-
Interleukin-6, a pleiotropic cytokine
Volume 8 Supplement 2
-
Gout and Hyperuricemia
Volume 8 Supplement 1
-
-
Volume 7
Back to top-
Gastroprotection: the role of proton pump inhibitors
Volume 7 Supplement 4
-
B cell targeted therapy: a new approach to the treatment of rheumatoid arthritis
Volume 7 Supplement 3
-
Basic science, rationale, background and future of abatacept
Volume 7 Supplement 2
-
25th European Workshop for Rheumatology Research
Volume 7 Supplement 1
-
-
Volume 6
Back to top-
Global Arthritis Research Network (GARN): 4th World Congress on Arthritis in Montreal
Volume 6 Supplement 3
-
Current and new antitumor necrosis factor agents in perspective
Volume 6 Supplement 2
-
24th European Workshop for Rheumatology Research
Volume 6 Supplement 1
-
-
Volume 5
Back to top-
Targeting B cells in autoimmune diseases
Volume 5 Supplement 4
-
23rd European Workshop for Rheumatology Research
Volume 5 Supplement 1
-
-
Volume 4
Back to top-
The Scientific Basis of Rheumatology
Volume 4 Supplement 3
-
Current perspectives on the treatment of rheumatic diseases with infliximab
Volume 4 Supplement 2
-
22nd European Workshop for Rheumatology Research
Volume 4 Supplement 1
-
-
Volume 3
Back to top -
Volume 1
Back to top-
Fourth International Synovitis Workshop
Volume 1 Supplement 1
-